Impact of Universal Admission Testing for Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) in Era of the Omicron Variant

Overview

Journal Infect Control Hosp Epidemiol

Publisher Cambridge University Press

Specialties Health Services
Infectious Diseases
Nursing
Public Health

Date 2023 Jan 18

PMID 36651289

Authors

Victoria R Williams

Christina K Chan

Adrienne K Chan

Robert Kozak

Jerome A Leis

Affiliations

Soon will be listed here.

Abstract

In this prospective study, universal admission testing for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) averted transmission in shared patient rooms especially since the emergence of the SARS-CoV-2 omicron variant when the yield in identifying infectious asymptomatic cases more than doubled. This change may be due to the higher rate of asymptomatic infection with the omicron variant, the broader community prevalence during the omicron era, or both.

Citing Articles

Comparing the effectiveness of universal admission testing and risk-based testing at emergency admission for preventing nosocomial COVID-19: a multicenter retrospective cohort study in Japan.

Iijima K, Osako H, Iwata K Infect Control Hosp Epidemiol. 2024; 1-9.

PMID: 39434373 PMC: 11717481. DOI: 10.1017/ice.2024.161.

Utility of routine post-admission testing for SARS-CoV-2 in a rehabilitation facility.

Williams V, Robinson L, Eisenberg M, Virdi K, Kozak R, Leis J Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e21.

PMID: 38415082 PMC: 10897725. DOI: 10.1017/ash.2024.14.

Effects of Different SARS-CoV-2 Testing Strategies in the Emergency Department on Length of Stay and Clinical Outcomes: A Randomised Controlled Trial.

Boldt K, Bolanaki M, Holert F, Fischer-Rosinsky A, Slagman A, Mockel M Can J Infect Dis Med Microbiol. 2024; 2024:9571236.

PMID: 38384429 PMC: 10881249. DOI: 10.1155/2024/9571236.

Non-Pharmacological Strategies and Interventions for Effective COVID-19 Control: A Narrative Review.

Aho Glele L, de Rougemont A J Clin Med. 2023; 12(20).

PMID: 37892603 PMC: 10607620. DOI: 10.3390/jcm12206465.

Incidence and outcomes of hospital-associated coronavirus disease 2019 (COVID-19) before and after emergence of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant.

Williams V, Tan C, Kozak R, Leis J Infect Control Hosp Epidemiol. 2023; 44(10):1698-1700.

PMID: 36876324 PMC: 10587372. DOI: 10.1017/ice.2023.29.